PharmAust |
High - |
Low - |
Trades - |
Turnover $0 |
Volume 0 |
| 13 November 2026 at 5:47am | ||||
|
Market Cap (13-Nov) $111,926,056 (1,449th) |
Close (30-Jun) $0.075 |
Volume (30-Jun) 0 |
Shortsold (11-Oct) 108,089 (0.02%) (492nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
Canine Cancer Trial Update
PAA released this announcement to the ASX on 7 March 2023, 8:19. The announcement is marked as price sensitive, and is 4 page(s) in length and 351.24kb in size.
You can view all announcements from PAA and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAA was 0.072% short sold according to ASIC data. It was ranked the 487th most shorted stock on the ASX. It remains ranked 492nd as of the latest reported data (11 October 2024).
| Other Recent Announcements from PAA | |
|---|---|
| Results of General Meeting | 30 June 2023, 12:38 |
| Trading Halt | 30 June 2023, 9:48 |
| General Meeting - Chairman Script | 30 June 2023, 9:42 |
| Canine Cancer Trial Update | 7 March 2023, 8:19 |
| Interim analysis recommended in MND trial | 2 March 2023, 8:14 |
| European Patent relating to MPL Combinations in Cancer | 28 February 2023, 7:57 |
| Appendix 4D & Half Year Report | 27 February 2023, 16:10 |
If you were already registered, log in here.